Niels Hofkes – Page 2

Homepage Lawyers Niels Hofkes Private Equity Track Record

Standard Investment acquires Micro Machining Group

We advised Standard Investment in the acquisition, together with management, of Micro Machining Group (MMG) from Aalberts Industries. MMG is a manufacturer of high-precision components to a wide range of customers and industries, including the defense, aerospace, medical and semiconductor industry. MMG is able to carry out milling and grinding operations with tolerances of a few thousandths of a millimeter. The specialization of MMG is in making small products with a size of a few millimeters to about 75 centimeters. Products are made from high quality metal, including titanium and specialty steel alloys.

Niels_Admin30 June 2016

Lawyers M&A Marcel van de Vorst Niels Hofkes Track Record

Sale of GreenPeak to Qorvo

We advised Gimv, Robert Bosch Venture Capital and DFJ Esprit on the sale of all outstanding shares in GreenPeak Technologies B.V. to Qorvo. GreenPeak is a fabless semiconductor/system company and makes ZigBee semiconductor products and software technologies for Smart Home data communications and the Internet of Things. Previously we advised GreenPeak Technologies on its 2013 equity financing round by existing shareholders comprising Gimv, Robert Bosch Venture Capital GmbH and DFJ Esprit II LP. We also advised on the company’s prior equity financing rounds and the acquisition of Ubiwave since 2007. * * Marcel van de Vorst led these earlier transactions whilst at previous law firm.

Niels_Admin2 May 2016

Lawyers Niels Hofkes Track Record

Fastned transfers from NPEX to Nxchange

We were involved with the introduction of Fastned, builder of European network of fast charging stations for electric vehicles, on the new stock exchange Nxchange. Fastned moves to Nxchange because this European exchange fits with the European expansion plans of Fastned. Nxchange operates (like Euronext) under license of the AFM as regulated market. As a result of the switch to a regulated market, more parties can invest in Fastned. Fastned expects that it will become easier to attract new capital and that the tradeability of the shares will improve. Our role in this listing related to the documentation for the transfer of the Fastned certificates from the NPEX platform to Nxchange.

Niels_Admin14 April 2016

Lawyers M&A Niels Hofkes Track Record

BOM sells shares Van Heinde to Sligro

We advised Brabantse Ontwikkelings Maatschappij (BOM) in the sale of its shares in Van Heinde to Sligro Group. Van Heinde is an innovative foodconcept, combining both retail and hospitality. Sligro Group converted Van Heinde to an EMTÉ 3.0 store, where Brasserie Van Heinde remains centrally located in the store.

Niels_Admin16 March 2016

Eveline Mutsaers Niels Hofkes Track Record Venture Capital

BOM provides growth financing to Vendinova Group

We advised the Brabantse Ontwikkelings Maatschappij (BOM) for an investment in the Vendinova Group from Nieuwkuijk. Vendinova wants to conquer the (inter)national market with the Soup-Server: the world's first soup dispenser for 100 percent natural, fresh soups.

Niels_Admin4 February 2016

M&A Niels Hofkes Track Record

Acquisition of Acerta Pharma by Astra Zeneca

We advised BOM Capital on the sale of its shares in Acerta Pharma to Astra Zeneca. BOM Capital was one of the early investors in Acerta Pharma. Astra Zeneca has taken a 55% stake in Acerta Pharma and an option to acquire the remaining 45% interest. This sale is after BioNovion the second successful exit in biotech for BOM Capital in 2015, is the largest in the history of BOM Capital and the largest biotech deal so far in the Netherlands.

Niels_Admin17 December 2015

Eveline Mutsaers M&A Niels Hofkes Track Record

BOM Capital sells shares in BioNovion to Aduro Biotech

We advised BOM Capital on the sale of its shares in BioNovion to Aduro Biotech. The company, based on the Pivot Park in Oss, is the new European headquarters of Nasdaq-listed Aduro Biotech and renamed in Aduro Biotech Europe. Aduro acquired BioNovion to broaden its technological portfolio and to increase the potential of immunotherapy. BioNovion develops monoclonal antibody therapies against cancer, on the basis of their unique platform technology and expertise in the field of immune therapy of cancer.

Niels_Admin15 November 2015

Niels Hofkes Private Equity Track Record

Standard Investment acquires Synres

We advised Standard Investment in the acquisition, together with management, of all shares in Synres B.V., a former subsidiary of Royal DSM N.V. Synres is a manufacturer of various types of high-quality, solvent-borne resins which act as a binder for coatings. The alkyd, acrylate, and urethane resins are made for the paint and coatings industry, in a wide range of applications such as decorative paints and coatings for metal (eg. ships, bridges, storage tanks, cars) and wood. Synres is located in Hook of Holland.

Niels_Admin16 July 2015

Niels Hofkes Private Equity Track Record

Standard Investment acquires Dutch Bakery Group

We advised Standard Investment in the acquisition of an industrial bakery in the Netherlands for low-oxygen packed bread products with a long shelf life. This bakery was sold by Bakkersland to Dutch Bakery Group, a collaboration between Standard Investment and her partner Dutch Bakery BV. Since the acquisition both companies operate under the name Dutch Bakery Group (DBG) and this results in a strong position as market leader in the Benelux and the established top five player in Europe for low-oxygen packed bread.

Niels_Admin30 January 2015

Niels Hofkes Private Equity Track Record

Standard Investment acquires HE Tubing

We advised Standard Investment on the acquisition of HE Tubing, a producer of aluminum micro-port extrusion (MPE) tubes that are used in particular for automotive air conditioning systems. The company is located in Harderwijk and offers state-of-the-art production facilities. HE Tubing was formerly part of the wider aluminum extrusion operations of Sapa.

Niels_Admin20 December 2013